Set to take place on 21st and 22nd January 2015, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential insights into the latest advancements in practice and technology, developments in regulation and the global harmonisation of evolving microbiology methods.
Join us as we ask questions such as, What are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms?
Hear presentations from an array of market leaders such as GSK, Genzyme, Abbott, MedImmune and AstraZeneca, address real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms.
TOP KEY SPEAKERS INCLUDE:
. Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
. Ruth Daniels, Head of MSAT, Microbiology, Genzyme
. Sara Gamberini, Molecular Biology Scientist, Merck Serono
. Hans Noordergraaf, Microbiologist, Abbott Biologicals
. Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
. Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
. Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
. Phil Duncanson, Director of QC, MedImmune
Register by 30th September and save £300, book by 31st October and save £100.
Alternatively contact the team on Tel: +44 (0)870 9090 711
Conference and 2 workshops: GBP2697+vat
Conference and 1 workshop: GBP2098+vat
Conference Only: GBP1499+vat
From: January 21, 2015 08:30
To: January 22, 2015 16:39
London Marriott Hotel Regents Park, 128 King Henry's Rd, NW3 3ST, United Kingdom